Pure Global
NCT06127069

Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device

Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device - A Randomized Parallel Arm Clinical Trial
Aristotle University Of Thessaloniki·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Periodontitis
Drug/Device/Intervention
chitosan brush
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Aristotle University Of Thessaloniki
Location
Thessaloniki, Greece
Timeline & enrollment
Phase
N/A
Start date
Sep 08, 2021
End date
Nov 29, 2022
Enrollment
36 participants
Primary outcome

Probing Pocket Depth,MMP-8

Summary

The aim of the current study was to investigate the effect of a chitosan brush on the
 treatment of residual pockets in patients already treated for periodontal disease. Thirty-six
 patients with chronic periodontitis (Stage ΙΙΙ, ΙV) that had already completed causative
 therapy and exhibited at least two residual periodontal pockets ≥ 5mm that bled on probing,
 were randomly assigned to two groups. In the test group debridement of residual pockets was
 performed with ultrasonic scaler and the chitosan brush, whereas in the control group only
 ultrasonic scalers were used.

ICD-10 classifications
Chronic periodontitisPeriodontosisAcute periodontitisChronic apical periodontitisPeriodontal disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06127069
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06127069 through Pure Global AI's free database. This phase not specified trial is sponsored by Aristotle University Of Thessaloniki and is currently Completed. The study focuses on Periodontitis. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.